Browse the corpus

Frontal lobe syndrome describes a constellation of cognitive, behavioral, emotional, and motivational disturbances resulting from dysfunction of frontal–subcortical networks, particularly the prefrontal cortex. Rather than a single lesion, it reflects disruption of circuits regulating executive function, impulse control, social behavior, and goal-directed activity. Common causes include traumatic brain injury, cerebrovascular disease, neurodegenerative disorders, tumors, infection, and metabolic or toxic injury. Clinical manifestations vary by circuit involvement and may include disinhibition, apathy, impaired judgment, executive dysfunction, and personality changes that significantly affect daily functioning and relationships. This activity reviews prefrontal cortex subdivisions, frontal–subcortical circuits, and mechanisms of network disconnection. It emphasizes recognition, appropriate diagnostic evaluation with neuroimaging and neuropsychological testing, and management strategies, including rehabilitation, medication optimization, and caregiver support, to improve patient outcomes and coordinate care. Objectives: Identify the common etiologies of frontal lobe syndrome. Evaluate the diagnostic findings of patients with suspected frontal lobe syndrome. Implement evidence-based treatment strategies for frontal lobe syndrome. Apply interprofessional strategies to optimize outcomes and care coordination for patients with frontal lobe syndrome. Access free multiple choice questions on this topic.

Frontal lobe syndrome is characterized by impairments in executive function, behavior, emotion, motivation, and personality resulting from damage to the frontal lobes, particularly the prefrontal cortex and its associated neural networks.[1][2][3] Although historically described following traumatic brain injury, most famously in the 1848 case of Phineas Gage, frontal lobe syndrome is now recognized as a network-based disorder arising from diverse etiologies, including cerebrovascular disease, neurodegeneration, neoplasms, infection, inflammation, and metabolic or toxic injury.[4][5] Clinical manifestations reflect disruption of frontal–subcortical circuits rather than isolated cortical lesions. Anatomy The frontal lobe, the largest cerebral lobe, lies anterior to the central sulcus and comprises the primary motor cortex, the supplementary and premotor cortices, and the prefrontal cortex. Injury to the motor and premotor regions produces contralateral weakness and impaired motor execution. The posteroinferior frontal gyrus of the dominant hemisphere (Broca area, Brodmann areas 44 and 45) mediates expressive language, and lesions result in nonfluent aphasia.[6][7] The prefrontal cortex (PFC), the anterior-most region of the frontal lobe, serves as the neuroanatomical substrate for higher-order cognitive processes, including working memory, planning, decision-making, behavioral regulation, and social cognition (see Image. Prefrontal Cortex).[7] As a heteromodal association cortex, it integrates convergent input from all sensory modalities and maintains extensive reciprocal connections with limbic structures (eg, amygdala, hippocampus), the basal ganglia, and the thalamus. These interconnected pathways form parallel, functionally segregated frontal–subcortical circuits that support distinct cognitive, behavioral, and motivational domains. Emerging evidence emphasizes the role of frontal–limbic integration in decision-making and adaptive behavior, supporting the conceptualization of frontal lobe syndrome as a disorder of dysfunction in the frontal–subcortical network rather than as an isolated cortical injury.[8][9] Functional Subdivisions of the Prefrontal Cortex Key factors of the dorsolateral prefrontal cortex (DLPFC) include: The DLPFC originates in the dorsolateral prefrontal cortex and projects to the dorsolateral caudate, globus pallidus, and thalamus.

The prefrontal cortex (PFC), the anterior-most region of the frontal lobe, serves as the neuroanatomical substrate for higher-order cognitive processes, including working memory, planning, decision-making, behavioral regulation, and social cognition (see Image. Prefrontal Cortex).[7] As a heteromodal association cortex, it integrates convergent input from all sensory modalities and maintains extensive reciprocal connections with limbic structures (eg, amygdala, hippocampus), the basal ganglia, and the thalamus. These interconnected pathways form parallel, functionally segregated frontal–subcortical circuits that support distinct cognitive, behavioral, and motivational domains. Emerging evidence emphasizes the role of frontal–limbic integration in decision-making and adaptive behavior, supporting the conceptualization of frontal lobe syndrome as a disorder of dysfunction in the frontal–subcortical network rather than as an isolated cortical injury.[8][9] Functional Subdivisions of the Prefrontal Cortex Key factors of the dorsolateral prefrontal cortex (DLPFC) include: The DLPFC originates in the dorsolateral prefrontal cortex and projects to the dorsolateral caudate, globus pallidus, and thalamus. Functions of this area include working memory, planning, cognitive flexibility, set-shifting, attention regulation, and problem solving. Lesions result in dysexecutive syndrome with impaired planning, reduced verbal fluency, poor working memory, and stimulus-bound behavior (may present with apathy and psychomotor slowing or "pseudo-depressive" syndrome.[10][11][12] Key factors of the orbitofrontal cortex (OFC) include: The OFC receives input from the amygdala, hippocampus, and sensory association cortices and projects to the ventral striatum, mediodorsal thalamus, hypothalamus, and back to limbic structures (including the amygdala). Functions of the OFC include impulse control, judgment, social cognition, emotional regulation, and reward-based decision making. Lesions result in disinhibition syndrome, manifesting as impulsivity, tactlessness, emotional lability, and socially inappropriate behavior ("pseudo-psychopathic" or "frontal lobe personality").[13][14] Lateral OFC lesions have been correlated with OCD, depression, irritability, and mania.[15][16][14][17] Key factors of the anterior cingulate cortex (ACC) include:

Lesions result in disinhibition syndrome, manifesting as impulsivity, tactlessness, emotional lability, and socially inappropriate behavior ("pseudo-psychopathic" or "frontal lobe personality").[13][14] Lateral OFC lesions have been correlated with OCD, depression, irritability, and mania.[15][16][14][17] Key factors of the anterior cingulate cortex (ACC) include: The ACC comprises the anterior cingulate gyrus and the supplementary motor area and connects the amygdala, lateral hypothalamus, brainstem centers, hippocampus, and ventral striatum. Functions of the ACC include motivation, initiation of goal-directed behavior, error monitoring, emotional processing, and autonomic regulation. Lesions result in apathetic/akinetic syndrome, which manifests as profound apathy, abulia (loss of will), reduced spontaneous movement, and speech. Severe bilateral lesions produce akinetic mutism, in which patients are awake but lack voluntary movement or speech.[18][19][20] Frontal–Subcortical Circuits Frontal lobe syndrome is best conceptualized as a dysfunction of parallel frontal–subcortical circuits that connect the prefrontal cortex to the striatum, globus pallidus, substantia nigra, and thalamus (see Table 1). Lesions affecting cortical regions, subcortical nuclei, or connecting white matter tracts can produce similar clinical syndromes, explaining why caudate, thalamic, or basal ganglia lesions may mimic primary frontal cortical damage (“subcortical frontal syndrome”).[21][18] Table Table 1. Frontal–Subcortical Circuits and Lesion Effects. Natural History The natural history of frontal lobe syndrome is etiology-dependent. Acute insults (stroke, traumatic brain injury, infection) may stabilize or demonstrate gradual improvement with targeted treatment and rehabilitation.[22] Neurodegenerative etiologies, particularly behavioral variant frontotemporal dementia (bvFTD), follow progressive decline over 6 to 11 years from symptom onset to death.[23][24] Tumor-related frontal lobe syndrome trajectories vary with histologic grade, location, and treatment response. Without appropriate intervention, frontal lobe syndrome typically results in progressive functional disability, social isolation, legal and financial complications, and substantial caregiver burden regardless of underlying etiology.[25]

Frontal lobe syndrome results from any process disrupting the prefrontal cortex or its connected circuits, including: Traumatic brain injury Cerebrovascular disease (ACA or frontal MCA territory infarcts) Neurodegenerative disorders (frontotemporal dementia, Alzheimer's disease) [24] Intracranial neoplasms (primary or metastatic) Idiopathic normal pressure hydrocephalus [26] Infectious or inflammatory conditions (eg, HSV encephalitis, neurosyphilis, HIV) Frontal lobe epilepsy Metabolic or toxic encephalopathies Iatrogenic injury (eg, neurosurgical intervention) [1][21][5]

Because frontal lobe syndrome is a syndrome rather than a discrete disease, prevalence data are derived from underlying etiologies. Frontotemporal dementia: prevalence approximately 10 to 30 per 100,000; accounts for an estimated 20% of early-onset dementia (<65 years) [27][28][29] Traumatic brain injury: approximately 2.9 to 3.5 million emergency department visits annually in the United States; frontal involvement is common due to anatomical vulnerability [29][30] Stroke: frontal lobe involvement occurs in a substantial proportion of ACA and MCA infarcts; poststroke frontal dysfunction affects 20% to 40% of survivors [31][32] Frontal lobe syndrome affects all age groups but is most commonly identified in middle-aged and older adults due to vascular and neurodegenerative causes.

Frontal lobe syndrome results from the disruption of distributed frontal–subcortical networks that mediate executive control, behavioral regulation, motivation, and emotional processing. These networks comprise parallel cortico–striato–pallido–thalamo–cortical loops linking the prefrontal cortex with the striatum, globus pallidus, substantia nigra, and thalamus.[33] Injury may occur at the cortical, subcortical, or white matter level, often producing clinically similar phenotypes through network disconnection rather than focal damage.[34] Pathophysiologic mechanisms vary by etiology. Neurodegenerative disorders such as behavioral variant frontotemporal dementia involve abnormal protein aggregation (tau in MAPT mutations; TDP-43 in GRN and C9orf72 mutations), leading to progressive neuronal loss and synaptic dysfunction in frontal and anterior temporal regions.[35] Traumatic brain injury causes diffuse axonal injury with secondary inflammatory cascades.[36] Cerebrovascular insults produce ischemic neuronal injury, with strategically located infarcts in frontal–subcortical circuits yielding disproportionate deficits.[37] Neoplasms disrupt networks via mass effect, infiltration, edema, and seizure activity.[38] Neuroimaging studies demonstrate that clinical manifestations correlate with the extent of network-level disconnection, supporting the view of frontal lobe syndrome as a disorder of distributed neural systems rather than of isolated regional pathology.[39]

The following histopathologic findings vary by etiology: Neurodegeneration: neuronal loss, gliosis, tau or TDP-43 inclusions [40] Vascular disease: infarction, hemorrhage, microvascular ischemic change [41] Traumatic brain injury: diffuse axonal injury, gliosis, hemorrhagic contusions [36] Neoplasms: tumor-specific histologic features [40]

Clinical History Patients typically present with behavioral, personality, or cognitive changes noted by family or caregivers. Impaired insight and anosognosia are common; therefore, collateral history is essential.[5] History should establish baseline functioning and clarify the onset and progression of symptoms. Acute onset suggests vascular events such as stroke, traumatic brain injury, or seizures, whereas subacute progression raises concern for infection, neoplasm, or autoimmune encephalitis. An insidious onset is more consistent with neurodegenerative disease or chronic hydrocephalus.[5][42][43] Core symptom domains include behavioral disinhibition, manifested by social inappropriateness, tactlessness, impulsivity, hypersexuality, criminal behavior, loss of manners, emotional lability, and irritability. Apathy and loss of motivation may present as reduced initiative, diminished interest in activities, emotional blunting, loss of empathy, and decreased spontaneous speech or movement. Executive dysfunction is common and includes impaired planning and organization, poor judgment, difficulty with multitasking, perseveration, stimulus-bound behavior, and reduced problem-solving ability. Reported memory complaints often reflect impaired encoding due to attentional deficits rather than primary amnestic processes. Language changes may include reduced speech output, echolalia, palilalia, stereotyped utterances, or semantic deterioration, particularly in semantic-variant primary progressive aphasia.[16][1][44] Functional impact should be assessed through real-world consequences such as occupational decline, deterioration in interpersonal relationships, financial mismanagement, legal problems, driving impairment, and safety concerns. Additional history should include past medical conditions such as prior stroke, head trauma, seizures, psychiatric diagnoses, and substance use, a thorough medication review with attention to polypharmacy and anticholinergic burden, family history of early-onset dementia, psychiatric illness, or movement disorders; and relevant social history, including alcohol use, occupational exposures, and educational background. Physical Examination

Functional impact should be assessed through real-world consequences such as occupational decline, deterioration in interpersonal relationships, financial mismanagement, legal problems, driving impairment, and safety concerns. Additional history should include past medical conditions such as prior stroke, head trauma, seizures, psychiatric diagnoses, and substance use, a thorough medication review with attention to polypharmacy and anticholinergic burden, family history of early-onset dementia, psychiatric illness, or movement disorders; and relevant social history, including alcohol use, occupational exposures, and educational background. Physical Examination A comprehensive mental status and neurological examination is essential when evaluating suspected frontal lobe syndromes. Clinical manifestations span cognitive, behavioral, language, and motor domains, and may vary depending on the specific frontal–subcortical circuits involved.[1] Cognitive and executive dysfunction is common and includes impaired planning, organization, and cognitive flexibility. Patients frequently demonstrate poor working memory, difficulty with multitasking, and reduced capacity for abstract reasoning. Executive testing may reveal impaired abstraction, decreased verbal fluency, difficulty with sequential motor tasks (eg, Luria 3-step test), and inaccurate cognitive estimates.[45] Behavioral and psychiatric manifestations often predominate and may include disinhibition, impulsivity, apathy, or abulia. Patients may exhibit poor social judgment, socially inappropriate behavior, emotional dysregulation, distractibility, impersistence, and environmental dependency, including utilization behavior. Insight into deficits is frequently impaired, and anosognosia is common.[5][8]

Behavioral and psychiatric manifestations often predominate and may include disinhibition, impulsivity, apathy, or abulia. Patients may exhibit poor social judgment, socially inappropriate behavior, emotional dysregulation, distractibility, impersistence, and environmental dependency, including utilization behavior. Insight into deficits is frequently impaired, and anosognosia is common.[5][8] Language and motor features depend on lesion laterality and extent. Clinical signs may include reduced speech output, perseveration, echolalia, dysarthria, hypophonia, or apraxia of speech. Expressive aphasia may occur with involvement of the dominant hemisphere. Motor findings can include impaired initiation of voluntary movement, contralateral weakness from primary motor cortex involvement, rigidity or bradykinesia due to subcortical pathology, and gait apraxia with medial frontal lesions. Abnormal eye movements, such as vertical gaze palsy, may suggest specific neurodegenerative etiologies, eg, progressive supranuclear palsy.[46][1] Primitive (frontal release) reflexes, including the grasp, snout, glabellar (Myerson), and palmomental reflexes, may be present but have limited diagnostic specificity and can be observed in normal aging.[47] Clinical presentations often overlap but may reflect disruption of distinct frontal-subcortical circuits, resulting in executive dysfunction, emotional or behavioral dysregulation, hypoemotional states characterized by apathy, or distress and anxiety syndromes.[45] A recognized phenomenon is the frontal lobe paradox, in which patients perform adequately on structured neuropsychological testing yet exhibit marked impairment in real-world functioning, reflecting a “knowing–doing dissociation.”[48] Importantly, the neurological examination may be normal in early disease, particularly in behavioral variant frontotemporal dementia; therefore, an unremarkable physical examination does not exclude frontal lobe pathology.[5]

Diagnosis relies on clinical evaluation demonstrating characteristic executive dysfunction, behavioral disturbances, and personality changes consistent with frontal lobe pathology, supported by findings from neuroimaging and neuropsychological testing.[49] Neuroimaging Neuroimaging plays a central role in identifying structural or functional abnormalities associated with frontal lobe syndrome. Brain magnetic resonance imaging (MRI) with or without contrast remains the preferred modality and evaluates patterns of cerebral atrophy, including frontotemporal involvement in behavioral variant frontotemporal dementia and medial temporal atrophy in Alzheimer disease, along with mass lesions, vascular pathology, white matter disease, and hydrocephalus.[50][49] Head computed tomography (CT) serves as an alternative in acute clinical settings and facilitates rapid identification of intracranial hemorrhage or large infarcts when MRI remains unavailable. Fluorodeoxyglucose positron emission tomography demonstrates frontal or anterior temporal hypometabolism in behavioral variant frontotemporal dementia when structural imaging fails to reveal diagnostic abnormalities.[50] Neuropsychological Testing Neuropsychological testing provides an objective assessment of executive dysfunction and functional impairment. Structured evaluation may reveal the “frontal lobe paradox,” in which preserved performance on formal testing contrasts with substantial impairment in real-world functioning.[1] Executive function tests commonly include the Wisconsin Card Sorting Test, Trail Making Test-B, Stroop test, verbal fluency tasks using phonemic or semantic categories, and the Tower of London task.[1] Screening instruments, eg, the Montreal Cognitive Assessment, Frontal Assessment Battery, and Addenbrooke's Cognitive Examination-III, assist with the detection of cognitive deficits.[51] Behavioral assessment tools include the Frontal Behavioral Inventory, the Neuropsychiatric Inventory, and the Frontal Systems Behavior Scale.[52] Laboratory Studies

Screening instruments, eg, the Montreal Cognitive Assessment, Frontal Assessment Battery, and Addenbrooke's Cognitive Examination-III, assist with the detection of cognitive deficits.[51] Behavioral assessment tools include the Frontal Behavioral Inventory, the Neuropsychiatric Inventory, and the Frontal Systems Behavior Scale.[52] Laboratory Studies Laboratory studies do not establish a diagnosis of frontal lobe syndrome but assist in identifying reversible or contributory conditions.[53] Routine screening commonly includes complete blood count, comprehensive metabolic panel, thyroid-stimulating hormone with free T4, vitamin B12 with or without methylmalonic acid, folate, rapid plasma reagin or VDRL testing, urinalysis, and urine drug screening. Additional investigations guided by clinical suspicion may include HIV testing, erythrocyte sedimentation rate or C-reactive protein, antinuclear antibodies or neuronal antibodies (eg, NMDA and LGI1), ceruloplasmin with urine copper measurement, very-long-chain fatty acids, and thiamine levels.[54] Cerebrospinal Fluid Cerebrospinal fluid analysis does not form part of routine evaluation but supports assessment when infection, inflammatory disease, autoimmune encephalitis, or diagnostic uncertainty arises.[55] Biomarker profiles may aid etiologic differentiation. Alzheimer disease often demonstrates decreased Aβ42 with increased total and phosphorylated tau. Frontotemporal dementia typically shows normal Aβ42 with normal or mildly elevated tau concentrations. Neurofilament light chain functions as a nonspecific biomarker of neurodegeneration.[56] Genetic Testing Genetic testing warrants consideration in patients with early disease onset before 65, positive family history, or atypical clinical presentations. Frequently implicated genes include C9orf72, MAPT, GRN, TARDBP, and FUS.[50] Electroencephalography Electroencephalography lacks a routine indication but assists in evaluation when seizures or autoimmune encephalitis are included in the differential diagnosis. Results are frequently normal or show nonspecific slowing.[57]

Management of frontal lobe syndrome requires an etiology-specific and interprofessional approach that addresses the underlying cause while mitigating cognitive, behavioral, and functional impairments. Etiology-Specific Treatment Treatments tailored to specific etiologies include: Stroke: reperfusion therapy when appropriate; secondary prevention Infections: antimicrobial therapy (acyclovir for HSV encephalitis, penicillin for neurosyphilis) Neoplasms: surgical resection, radiation, chemotherapy Normal pressure hydrocephalus: ventriculoperitoneal shunting [26] Autoimmune encephalitis: immunotherapy (eg, corticosteroids, IVIG, and plasmapheresis) Metabolic: thiamine replacement (Wernicke encephalopathy), copper chelation (Wilson disease) Neurodegenerative disease: no disease-modifying therapies exist; management focuses on symptomatic treatment. Pharmacologic Management Pharmacologic therapy targets predominant behavioral and motivational symptoms. However, no medications have received FDA approval specifically for frontal lobe syndrome. Medications for symptoms include: Behavioral symptoms (eg, disinhibition and agitation) First-line: SSRIs (sertraline, citalopram, escitalopram) show modest efficacy for behavioral symptoms in frontotemporal dementia [58] Second-line: trazodone 25 to 200 mg daily for agitation and sleep disturbance [58] Antipsychotics: reserved for severe, refractory symptoms due to limited efficacy and increased mortality risk in dementia; use the lowest dose for the shortest duration (quetiapine 25-100 mg, aripiprazole 2.5-10 mg) [59] Apathy Methylphenidate: 5-20 mg daily (often divided twice daily) may improve apathy; limited evidence [60] Contraindicated Cholinesterase inhibitors: may worsen behavioral symptoms in behavioral variant frontotemporal dementia Benzodiazepines: avoid due to cognitive worsening and fall risk Anticholinergic medications: worsen cognitive function Nonpharmacologic Interventions Nonpharmacologic interventions form the foundation of management and address behavioral symptoms, safety concerns, and functional decline.[25][50] These therapies include: Behavioral and environmental strategies Structured daily routines Environmental modification to reduce stimulation and promote safety Redirection and distraction techniques Positive reinforcement Cognitive rehabilitation, eg, goal-directed training focused on compensatory strategies, use of external memory aids (calendars, lists, reminders)

Behavioral and environmental strategies Structured daily routines Environmental modification to reduce stimulation and promote safety Redirection and distraction techniques Positive reinforcement Cognitive rehabilitation, eg, goal-directed training focused on compensatory strategies, use of external memory aids (calendars, lists, reminders) Physical/occupational therapy to maintain mobility, home safety evaluation, and fall prevention Speech-language pathology eg, communication strategies, swallowing evaluation Safety and legal considerations Driving: Assess driving safety; consider a formal evaluation. Patients with moderate-severe executive dysfunction should stop driving. Financial management: Implement protective measures (eg, a power of attorney, a representative payee). Advance care planning: Initiate early while the patient retains capacity. Caregiver support Essential components include education, behavioral management training, respite care, support groups, and connections to community resources

The differential diagnosis for frontal lobe syndrome is broad and includes: Psychiatric disorders: schizophrenia, bipolar disorder, major depression, personality disorders Other dementias: Alzheimer disease, dementia with Lewy bodies, vascular dementia Movement disorders: Parkinson disease with dementia, progressive supranuclear palsy, Huntington disease Structural lesions: subdural hematoma, hydrocephalus Infectious/inflammatory: encephalitis, autoimmune encephalitis Metabolic/toxic: vitamin deficiencies, thyroid disorders, medication effects, chronic alcohol use Other: epilepsy (frontal lobe epilepsy with interictal changes), chronic traumatic encephalopathy

Prognosis depends on etiology. Reversible causes (treated infections, resected tumors, corrected metabolic disorders, shunting for idiopathic normal pressure hydrocephalus) may show significant improvement. Traumatic brain injury recovery varies with injury severity, with younger age predicting better outcomes. Frontal stroke recovery occurs primarily within 3 to 6 months.[22] Frontotemporal dementia median survival is 6 to 11 years from symptom onset, with progressive functional decline.[23] Frontal lobe syndrome substantially impacts quality of life, relationships, and caregiver well-being regardless of etiology.[25]

Complications of frontal lobe syndromes are cause-specific. Progressive neurodegenerative disorders have social and behavioral complications requiring multifaceted support services for the patients and their families.

The most important aspect of treatment is patient and family education in patients affected by these syndromes. Patients suffer from cognitive, behavioral, and physical symptoms. Patients and their families need to be educated on the importance of providing supportive and safe environments for patients who will likely have a progressive decline in functional and cognitive abilities. Referrals to social work and other supportive services should be made early to help them cope with the changing needs of the patient.

Frontal lobe syndrome is due to a broad array of pathologies ranging from trauma to neurodegenerative diseases. The most important clinical feature is the dramatic change in cognitive function (eg, executive processing), language, attention, and behavior.

Frontal lobe syndrome describes a clinical condition characterized by impairments in executive function, behavior, motivation, and personality resulting from disruption of frontal–subcortical networks involving the prefrontal cortex and associated circuits. Diverse etiologies may produce this syndrome, including traumatic brain injury, cerebrovascular disease, neurodegenerative disorders, neoplasms, infection, autoimmune disease, and metabolic or toxic injury. Clinical manifestations commonly include disinhibition, apathy, impaired judgment, executive dysfunction, and socially inappropriate behavior, often leading to significant functional impairment. Diagnosis relies on careful clinical assessment supported by neuroimaging, neuropsychological testing, and targeted laboratory studies. Management focuses on identifying and treating the underlying cause while addressing behavioral symptoms, functional decline, and safety concerns through pharmacologic and nonpharmacologic strategies. Effective management requires coordinated interprofessional care. Physicians and advanced practitioners apply diagnostic expertise, interpret neuroimaging and cognitive assessments, and develop individualized treatment plans that address underlying etiologies and symptom management. Nurses monitor behavioral and cognitive changes, implement environmental and behavioral interventions, and identify safety concerns. Pharmacists review medication regimens to reduce polypharmacy and optimize pharmacologic treatment of behavioral symptoms. Social workers, therapists, and care coordinators support advance care planning, caregiver education, and access to community resources. Clear communication, shared decision-making, and coordinated care strategies strengthen patient-centered management, improve functional outcomes, reduce caregiver burden, and enhance overall team performance.